معرفی
Prof. Dr. Hannelore Ehrenreich is a faculty member at Heidelberg University's Medical Faculty Mannheim, affiliated with the Central Institute of Mental Health (ZI) in Mannheim, Germany. She serves as head of the Research Group for Experimental Medicine within the Department of Psychiatry and Psychotherapy, conducting interdisciplinary neuroscience research with clinical applications.
Her research spans molecular neuroscience and psychiatric disorders, focusing on erythropoietin-mediated neuroprotection, myelin biology, and brain metabolism. Key investigations include oligodendroglial energy metabolism, amyloid-β deposition mechanisms in Alzheimer's models, and genomic pathways in schizophrenia. Her work bridges basic science with therapeutic development for neurodegenerative and psychiatric conditions.
Recent publications reveal consistent emphasis on cellular metabolism-neurodegeneration interactions, particularly lipid metabolism in glial cells and erythropoietin's role in neural plasticity. The research demonstrates strong translational focus, connecting molecular pathways to cognitive outcomes across Alzheimer's, schizophrenia, and hypoxia models through multi-institutional collaborations.
No scientific awards were documented in the source material.
Prof. Ehrenreich leads the Experimental Medicine research group at ZI, which maintains active partnerships with international consortia including the Schizophrenia Working Group of the Psychiatric Genomics Consortium and SynGO Consortium. The group employs multidisciplinary approaches spanning molecular biology, neuroimaging, and clinical psychiatry to investigate fundamental brain mechanisms.
